Literature DB >> 15257093

N(omega)-nitro-L-arginine methyl ester effects on neutrophil function and bacterial clearance.

Sebastian N Stehr1, Sören Weber, Susanne C Heller, Jutta Weikel, Matthias Hübler, Thea Koch, Axel R Heller.   

Abstract

Nitric oxide synthase (NOS) inhibitors are considered promising as a therapeutic option in severe septic shock. The aim of this study was to investigate the effects of N-nitro-L-arginine methyl ester (L-NAME) application on neutrophil (PMN) respiratory burst, phagocytosis, and elimination of Escherichia coli from blood and tissue in rabbits. Twenty-eight female chinchilla rabbits were randomized to a treatment and control group. To quantify the bacterial clearance process, 10 colony forming units (CFU) of E. coli were injected intravenously into anesthetized rabbits. Animals in the L-NAME group had a significantly higher mortality compared with controls. NOS inhibition resulted in a significant delay of bacterial clearance (P < 0.001). These findings correlated with a significant augmentation of all organ E. coli findings (P = 0.002-0.035). PMN phagocytosis activity was notably reduced by L-NAME treatment during the experimental observation. Neutrophil burst, on the other hand, was amplified by NOS inhibition (P = 0.008). Our findings point to an interference with the PMN-dependent immune mechanisms after L-NAME treatment. The augmented PMN burst reaction could be a compensatory mechanism, potentially leading to tissue damage. Therefore, in this model, we find sufficient evidence pointing to a possible cause for the deleterious effect of early nonselective NOS inhibition in critically ill patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15257093     DOI: 10.1097/01.shk.0000132487.89800.15

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  3 in total

1.  Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation.

Authors:  Steven W Barger; Mary E Goodwin; Mandy M Porter; Marjorie L Beggs
Journal:  J Neurochem       Date:  2007-03-30       Impact factor: 5.372

Review 2.  Differentiated control of deranged nitric oxide metabolism: a therapeutic option in sepsis?

Authors:  Corinna Lupp; Silke Baasner; Can Ince; Frank Nocken; John F Stover; Martin Westphal
Journal:  Crit Care       Date:  2013-05-29       Impact factor: 9.097

3.  IgM-enriched solution BT086 improves host defense capacity and energy store preservation in a rabbit model of endotoxemia.

Authors:  S Shmygalev; M Damm; L Knels; A Strassburg; K Wünsche; R Dumke; S N Stehr; T Koch; A R Heller
Journal:  Acta Anaesthesiol Scand       Date:  2015-11-11       Impact factor: 2.105

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.